The Munich medtech startup Symphera develops surgical systems for laparoscopic procedures that automate instrument changes and eliminate manual instrument switching. With the push of a button, surgeons can seamlessly switch between instruments, allowing them to focus entirely on the surgical procedures. This is intended to simplify the surgical workflow, shorten operation time, and improve patient care.
Symphera: focus on product development and preclinical studies
According to the company, the newly raised funds will be invested in product development and the implementation of initial preclinical studies to prepare for certification. These milestones are crucial in bringing Symphera’s technology closer to market readiness, with the goal of transforming laparoscopic surgery and sustainably improving patient care.
Jan Engels, investment manager at HTGF, says:
“With their surgical tool, Symphera addresses the complete spectrum of laparoscopy, from improving standard workflows to robotic-assisted applications, making Symphera a strong venture case in a highly interesting field.”
“An exciting investment case in the medtech sector”
Monika Steger, managing director of Bayern Kapital, adds:
“The Symphera team has developed an all-in-one instrument that enables shorter operations. Symphera’s already existing prototype convinced us and makes Symphera an exciting investment case in the medtech sector for us.”
And Christian Leikert, managing partner of Carma Fund, adds:
“We are impressed by Symphera’s founders and the potential to revolutionize laparoscopic surgery with an intuitive solution. The possible future application in robotic and robot-assisted surgery offers the company significant additional prospects.”
